China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

Beijing’s action against clothing maker PVH and biotech company Illumina underlines risk created by trade tensions ...

Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...

Market OverviewThe Global Carrier Screening Market is a genetic testing process that determines whether an individual carries ...

Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...

Illumina, Inc. (NASDAQ:ILMN – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Wednesday after Morgan Stanley lowered their price target on the stock from $150.00 to ...

Through new partnerships with industry leaders, Nvidia aims to help advance practical use cases for AI in healthcare and life ...

The provision will enable whole genome sequencing for neonatal and paediatric patients in intensive care units within 48 ...

INTEGRA Biosciences offers liquid handling solutions and magnetic modules to streamline every stage of NGS sample preparation ...

Researchers have created a novel imaging-technology combination that can capture gene activity in individual bacteria in ...